Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Clinical Challenges

News
Young Adults’ Use of Non-LSD Hallucinogens Increasing
06/09/2023
Past-year use of non-LSD hallucinogens among young adults between the ages of 19 and 30 nearly doubled, according to a study conducted by researchers from the University of Michigan and Columbia University.
Past-year use of non-LSD hallucinogens among young adults between the ages of 19 and 30 nearly doubled, according to a study conducted by researchers from the University of Michigan and Columbia University.
Past-year use of non-LSD...
06/09/2023
Addiction Professional
Aaron Olson
News
Interventions Help Clinicians Overcome Compassion Fatigue
06/01/2023
West Coast Symposium presenter Aaron Olson, MS, CMHC, SUDC, discusses the signs and symptoms of compassion fatigue, burnout, and trauma, and offers interventions to help practitioners restore their compassion resilience.
West Coast Symposium presenter Aaron Olson, MS, CMHC, SUDC, discusses the signs and symptoms of compassion fatigue, burnout, and trauma, and offers interventions to help practitioners restore their compassion resilience.
West Coast Symposium presenter...
06/01/2023
Addiction Professional
Lawrence Weinstein, MD
Perspectives
Xylazine Crisis: 6 Things Treatment Providers Should Know
05/23/2023
Despite being classified as an emerging drug threat by the Office of National Drug Control Policy, xylazine is still flying under the radar for many providers. Here is the least you need to know about the drug also known as "tranq."
Despite being classified as an emerging drug threat by the Office of National Drug Control Policy, xylazine is still flying under the radar for many providers. Here is the least you need to know about the drug also known as "tranq."
Despite being classified as an...
05/23/2023
Addiction Professional
News
Black, Hispanic Patients Receive MOUD After Opioid-Related Events Less Frequently Than White Patients
05/16/2023
A study by researchers at Harvard University and Dartmouth College shows a discrepancy in the rates in which various populations receive medications for opioid use disorder despite making a similar number of visits to healthcare providers.
A study by researchers at Harvard University and Dartmouth College shows a discrepancy in the rates in which various populations receive medications for opioid use disorder despite making a similar number of visits to healthcare providers.
A study by researchers at...
05/16/2023
Addiction Professional
Young Men With Cannabis Use Disorder Face Increased Risk of Schizophrenia
05/05/2023
Young men with cannabis use disorder are at an increased risk of developing schizophrenia, according to a study released this week by the National Institute on Drug Abuse and the Mental Health Services in the Capital Region of Denmark.
Young men with cannabis use disorder are at an increased risk of developing schizophrenia, according to a study released this week by the National Institute on Drug Abuse and the Mental Health Services in the Capital Region of Denmark.
Young men with cannabis use...
05/05/2023
Addiction Professional
Scott Weiner, MD, MPH, Michelle Hendricks, PhD, and Sanae El Ibrahimi, PhD, MPH
News
Linking Data Sets Critical for Unlocking Big Data’s Potential for Improving Addiction Treatment
05/02/2023
Rx Summit presenters Scott Weiner, MD, MPH, Michelle Hendricks, PhD, and Sanae El Ibrahimi, PhD, MPH, explain how merging public data sets can provide deeper insights into addiction and ways interventions can be improved.
Rx Summit presenters Scott Weiner, MD, MPH, Michelle Hendricks, PhD, and Sanae El Ibrahimi, PhD, MPH, explain how merging public data sets can provide deeper insights into addiction and ways interventions can be improved.
Rx Summit presenters Scott...
05/02/2023
Psychiatry & Behavioral Health
News
Researchers Identify Association Between Stimulant Therapy for ADHD and Rates of Stimulant Misuse Among Teens
04/20/2023
In a new study backed by NIDA, a strong association has been identified between prevalence of prescription stimulant therapy for attention-deficit/hyperactivity disorder (ADHD) and rates of stimulant misuse among middle and high school...
In a new study backed by NIDA, a strong association has been identified between prevalence of prescription stimulant therapy for attention-deficit/hyperactivity disorder (ADHD) and rates of stimulant misuse among middle and high school...
In a new study backed by NIDA, a...
04/20/2023
Addiction Professional
News
Overdose Prevention Centers Get Spotlight at Rx Summit
04/13/2023
For the first time in the 12-year history of the Rx and Illicit Drug Summit, the topic of overdose prevention centers took center stage on Thursday morning, with stakeholders involved with OPCs in the US convening for a panel.
For the first time in the 12-year history of the Rx and Illicit Drug Summit, the topic of overdose prevention centers took center stage on Thursday morning, with stakeholders involved with OPCs in the US convening for a panel.
For the first time in the...
04/13/2023
Addiction Professional
News
ONDCP Designates Fentanyl-Xylazine Combo as Emerging Drug Threat
04/12/2023
ONDCP Director Rahul Gupta, MD, MPH, MBA, FACP, announced during an Rx Summit plenary session on Wednesday that fentanyl combined with xylazine has been designated as an emerging threat to the United States.
ONDCP Director Rahul Gupta, MD, MPH, MBA, FACP, announced during an Rx Summit plenary session on Wednesday that fentanyl combined with xylazine has been designated as an emerging threat to the United States.
ONDCP Director Rahul Gupta, MD,...
04/12/2023
Addiction Professional
News
More Dangerous Substances Require More Proactive Efforts, Officials Say
04/12/2023
With deaths involving fentanyl and xylazine rising, NIDA Director Nora Volkow, MD, NIH Director Lawrence Tabak, DDS, PhD, and NIAAA Director George Koob, PhD, presented research updates and developments in substance use disorder treatment to...
With deaths involving fentanyl and xylazine rising, NIDA Director Nora Volkow, MD, NIH Director Lawrence Tabak, DDS, PhD, and NIAAA Director George Koob, PhD, presented research updates and developments in substance use disorder treatment to...
With deaths involving fentanyl...
04/12/2023
Addiction Professional

Advertisement

Advertisement

Browse Our Other Brands

Psych NP Institute

 

Psych Congress Network

 

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement